WitrynaImatinib mesylate is approved to treat: Acute lymphoblastic leukemia in adults and … Witryna· Trade name: Imatinib (mesylate) · Article number: 13139 · CAS Number: 220127 …
Imatinib mesylate CAS 220127-57-1 SCBT - Santa Cruz …
WitrynaImatinib mesilate The active substance is the mesylate salt form of imatinib, a phenylaminopyrimidine derivative and is the 4-[(4-methyl-1-piperazinyl) methyl] – N – [4-methyl-3-[ [4-(3-pyridinyl)-2-pyrimidinyl] amino]-phenyl]-benzamide methanesulfonic acid salt. It is a white to slightly yellowish crystalline powder and WitrynaWC,COA,MOA,DMF,SDS,MSDS,LOCAL GMP,DML,ISO9001 certificated, etc.. 8 production lines, 12 years experience, 2800 ㎡ R&D building，etc Our main products cover Ganciclovir,Sitagliptin,Empagliflozin, Imatinib mesylate,Silodosin，Molnupiravir..etc as API and its Intermediate. Waiting for you … iris pictures free
Imatinib Accord, INN-imatinib - European Medicines Agency
WitrynaImatinib Mesylate Tablets. Getwell Pharmaceuticals 474, Udyog Vihar, Phase-V, … WitrynaImatinib is approximately 95% bound to human plasma proteins, mainly albumin and alpha1-acid glycoprotein. The drug is eliminated predominantly via the bile in the form of metabolites, one of which (CGP 74588) shows comparable pharmacological activity to the parent drug. The faecal to urinary excretion ratio is approximately 5:1. WitrynaImatinib Mesylate Tablets North America GHS According to Federal Register / Vol. … porsche design kitchen price